Elbit Medical Technologies Ltd
ELBDF
$0.05
-$0.01-16.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 827.00K | -7.00M | -14.83M | -16.31M | -17.79M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.32M | 6.49M | 14.29M | 15.76M | 17.22M |
| Change in Net Operating Assets | -47.00K | -46.50K | -46.00K | -32.50K | -19.00K |
| Cash from Operations | -542.00K | -562.00K | -582.00K | -586.00K | -590.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 164.00K | 163.00K | 162.00K | 1.09M | 2.02M |
| Cash from Investing | 164.00K | 163.00K | 162.00K | 1.09M | 2.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -12.00K | -20.00K | -28.00K | -31.50K | -35.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -390.00K | -419.00K | -448.00K | 473.50K | 1.40M |